Skip to main content
OpenTrials

Clinical trial condition

Refractory Mismatch-repair-proficient (pMMR) Metastatic Colorectal Cancer

Explore clinical trials studying Refractory Mismatch-repair-proficient (pMMR) Metastatic Colorectal Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Refractory Mismatch-repair-proficient (pMMR) Metastatic Colorectal Cancer trial results

Recruiting

Sequential Immunochemotherapy Treatment with Pembrolizumab Plus Dendritic Cell (DC) Vaccine Followed by Trifluridine/Tipiracil Plus Bevacizumab in Refractory Mismatch-repair-proficient (pMMR) or Microsatellite-stable (MSS) Metastatic Colorectal Cancer

NCT06522919

Conditions
Colonic Diseases, Colorectal Cancer Metastatic, Colorectal Neoplasms, +11 more
Locations
  • IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"-IRST S.r.l. Meldola, Forlì Cesena, Italy
  • Pia Fondazione di Culto e Religione Azienda Ospedaliera "Card.G.Panico" Tricase, Lecce, Italy
View Trial Details

Related conditions